Prostate Cancer
PIONEER big data platform for prostate cancer: lessons for advancing future real-world evidence research.
September 13, 2024
Radical Prostatectomy Versus Stereotactic Radiotherapy for Clinically Localised Prostate Cancer: Results of the PACE-A Randomised Trial.
September 13, 2024
Safety and feasibility of "three arms settings" robot-assisted radical prostatectomy using the Hugo RAS system: surgical set-up in a double-center large case series.
September 12, 2024
Moderately hypofractionated prostate-only versus whole-pelvis radiotherapy for high-risk prostate cancer: A retrospective real-world single-center cohort study.
September 12, 2024
Silver Nanoparticles (AgNPs) Uptake by Caveolae-Dependent Endocytosis is Responsible for Their Selective Effect Towards Castration Resistant Prostate Cancer.
September 12, 2024
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study.
September 12, 2024
Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization.
September 12, 2024
Study Confirms AI Outperforms Conventional Methods for Prostate Cancer Extracapsular Extension Detection, Offering More Accurate Risk Assessments for Surgical Decisions
September 11, 2024
Extracapsular extension risk assessment using an artificial intelligence prostate cancer mapping algorithm
September 11, 2024
Testosterone recovery after androgen deprivation therapy.
September 11, 2024
Hospital-Level Variability in the Adoption of Image-Guided Focal Therapy for Localized Prostate and Kidney Cancer.
September 11, 2024
Prevention of Prostate Cancer Metastasis by a CRISPR-delivering Nanoplatform for Interleukin-30 Genome Editing.
September 11, 2024
Artificial Intelligence Improves the Ability of Physicians to Identify Prostate Cancer Extent.
September 11, 2024
A new silicon phthalocyanine dye induces pyroptosis in prostate cancer cells during photoimmunotherapy.
September 10, 2024
Emergency and non-emergency routes to cancer diagnoses in 2020 and 2021: A Population-based study of 154,863 patients.
September 10, 2024
Effect of concomitant medications on treatment response and survival in non-metastatic castrate resistant prostate cancer: Exploratory analysis of the SPARTAN trial.
September 10, 2024